Affiliation:
1. Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland
Abstract
Alpha-1 antitrypsin deficiency (AATD) is a common inherited disorder associated with an increased risk of pulmonary disease. Its clinical presentation, including the nature and severity of organ involvement, is highly variable and unpredictable and is not as strongly linked to genotype and environmental exposure (e.g., smoking history) as might be expected. Significant differences were observed within matched populations of severe AATD patients regarding risk of complications, age at onset, and disease course, including the dynamics of lung function decline. Genetic factors are among the putative modifiers contributing to the clinical variability in AATD, yet their role remains elusive. Here, we review and summarise our current understanding of epigenetic and genetic modifiers of pulmonary dysfunction in subjects with AATD.
Funder
Polish National Science Centre
Reference49 articles.
1. Disease burden associated with alpha-1 antitrypsin deficiency: Systematic and structured literature reviews;Miravitlles;Eur. Respir. Rev.,2022
2. Lechowicz, U., Rudzinski, S., Jezela-Stanek, A., Janciauskiene, S., and Chorostowska-Wynimko, J. (2020). Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein. Int. J. Mol. Sci., 21.
3. (2022, November 10). orpha.net. Available online: https://www.orpha.net/consor/cgi-bin/index.php.
4. Alpha1-antitrypsin deficiency: New therapies on the horizon;Remih;Curr. Opin. Pharmacol.,2021
5. A-1-antitrypsin deficiency: Clinical variability, assessment, and treatment;Stockley;Trends Mol. Med.,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献